This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Rosa Tye presents on the topic of “The Implications of the Inflation Reduction Act for Drug Market Access.”
For more information on this event, click here.
Recently, there has been heightened focus on dual brand approaches in which the same molecule is approved for multiple indications and packaged, priced, and...